Instinct Bio Technical

BIOT

Current Valuation

--P/E
Stock price$0.39

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
020406080

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-56.30x148.64%$182.40B
MRNAUSModerna
-24.96x15.52%$78.65B
CSLLYUSCSL Limited
-23.42x--$60.39B
NTRAUSNatera
-292.86x6.99%$56.33B
RVMDUSRevolution Medicines
-22.80x62.23%$40.32B
ROIVUSRoivant Sciences
-92.81x146.49%$24.71B
BNTXUSBioNTech SE
-11.81x19.72%$23.13B
INSMUSInsmed
-25.07x74.21%$21.94B
SMMTUSSummit Therapeutics
-16.00x19.55%$13.70B
BBIOUSBridgebio Pharma
-18.38x28.48%$12.71B
MDGLUSMadrigal Pharma
-33.89x51.06%$11.02B
IBRXUSImmunityBio
-10.58x151.32%$10.50B
TWSTUSTwist Bioscience
-73.22x28.88%$10.01B
PCVXUSVaxcyte
-9.09x49.36%$9.67B
KYMRUSKymera Therapeutics
-30.33x4.94%$9.09B
CYTKUSCytokinetics
-9.64x6.46%$8.62B
ARWRUSArrowHead Pharma
-26.82x36,308.30%$8.58B
ABVXUSAbivax SA
-16.67x22.49%$7.76B
PRAXUSPraxis Precision Medicines
-21.70x3.05%$7.36B
IONSUSIonis Pharma
-12.73x50.60%$7.20B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.